To investigate the factors that affect Aricept medication persistence rate and the safety and efficacy in patients with Alzheimer's Disease in clinical practice
Inclusion criteria:
Patients diagnosed with Alzheimer's Disease and administered Aricept for the first time.
Exclusion criteria:
Patients with a history of hypersensitivity to any ingredients of Aricept or piperidine derivatives.
Multiple Locations, Japan